DOI: 10.36347/sajb.2016.v04i04.007

Pages: 335-341

Acinetobacter baumannii is an ubiquitous pathogen that has emerged as a major cause of healthcare associated infections. Acinetobacter baumannii usually causes respiratory tract, urinary tract, blood stream and surgical site infections. During the period of study from January 2015 to December 2015, a total of 237 strains of A. baumannii were isolated from various clinical specimens obtained from hospitalized patients. Majority of isolates were obtained from 181 miscellaneous samples(76%) (Sputum(43%), HVS(29%), Pus(20%), DTT(3%), Throat(2%), Endo Tracheal(1%), Eye swab(1%) and Aspirates(1%) and followed by total of 56 Acinetobacter baumanii(24%) bacterial growth were isolated from urine culture. In Our study, cefazolin the first generation of cephalosporins showed 59% resistant and Ampicillin belonging to the penicillin group showed 58% resistant to Acinetobacter baumannii and remaining drugs showed sensitivity to the tested antibiotics. The drug susceptibility pattern is varied according to the area and environs. In our study, majority of them were found to be sensitive to the tested antibiotics, Amikacin the (aminoglycosides group) and Imipenem (carbapenem group) are the most effective antimicrobial agent against A. baumannii., so the controlment of utilisation of antibiotics in hospitals, play an crucial role in anticipation of the emergence of Acinetobacter baumanii.